Literature DB >> 7372443

Endocrine manipulation of the Dunning prostatic adenocarcinoma.

F S Shessel, N L Block, B Stover, A Claflin, T I Malinin, V A Politano.   

Abstract

The Dunning animal model was used to evaluate endocrine management of prostatic adenocarcinoma. Hypophysectomy, alone or in combination, and orchiectomy plus stilbestrol were the most effective means of suppressing tumor growth. Medical adrenalectomy by aminoglutethimide administration was as effective as surgical ablation. Accessary organ weights bore no direct relationship to the inhibition of tumor growth.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7372443

Source DB:  PubMed          Journal:  Invest Urol        ISSN: 0021-0005


  6 in total

1.  Direct effects of oestradiol on growth and morphology of the Dunning R3327H prostatic carcinoma.

Authors:  L Daehlin; A Bergh; J E Damber
Journal:  Urol Res       Date:  1987

2.  Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.

Authors:  T W Redding; A V Schally; T R Tice; W E Meyers
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  Inhibition of the growth of some hormone dependent tumors by D-Trp6-LH-RH.

Authors:  A V Schally; T W Redding; A M Comaru-Schally
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

4.  Prostate carcinoma tumor size in rats decreases after administration of antagonists of luteinizing hormone-releasing hormone.

Authors:  T W Redding; D H Coy; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

5.  Blood flow in the Dunning R3327H rat prostatic adenocarcinoma; effects of oestradiol and testosterone.

Authors:  L Daehlin; J E Damber
Journal:  Urol Res       Date:  1986

6.  Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.